DISASTERS AVERTED — Near Miss Case Studies
TOP STORIES — Diabetes News and Research
Provider Empathy Linked to Cardiovascular and Mortality Risk in Diabetes
Pioglitazone or Sulfonylureas in Patients with Pretreatment Cardiovascular Risk
Stillbirth Risk In Pregnant Women With Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Intermittent Fasting Beneficial for Weight Loss and Glycemic Control
#2 Updated Consensus Report on Diabetic Nutrition Therapy
#3 Preventing Type 2 Diabetes through Vitamin D3 Supplementation
Editor's Note
Last week I was working on a project, and it seemed like I was spending my whole day looking at spreadsheets and pivot tables. As the day went by I kept making the numbers larger to make it easier to read, and finally I had to give up for a few hours because it was hard to focus. I am sure all of us, especially when we get older, have this problem from time to time; however, we can turn away from the screen to rest our eyes. The question is, what do you do if you have to draw up an insulin dose and you have vision problems?
This week our good friend and fellow CDE, Ann Williams, shares her experience with a patient who could read the syringes but had a totally different problem. Click here to find out what the problem was.
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
I visited a housebound patient who had uncontrolled blood glucose, in spite of her physician having increased her insulin dose over a period of two weeks to twice her previous dose. The physician requested that I ask in depth about any factors that might be causing her to need so much more insulin.
TOP STORIES — Diabetes News and Research
This data supports previous research that linked provider empathy with clinical outcomes in patients with diabetes.
Cardiovascular risks in patients with type 2 diabetes using sulfonylureas vs. pioglitazone: personalized care approach.
Body mass index and glucose control play a role in the higher stillbirth risk for pregnant women with diabetes.
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
